Platelet-rich Plasma treatment of refractory ulcers with hyaluronic acid scaffolds

Platelet-rich Plasma treatment of refractory ulcers with hyaluronic acid scaffolds - PRP treatment of ulcers with HA scaffolds

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008428

Enrollment

Registered

2012-07-26

Start date

2012-07-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory ulcers, Foot ulcers

Interventions

Local injection of PRP with hyaluronic acid scaffolds together with standard therapy using ointment and dressing materials Standard therapy using ointment and dressing materials

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Chronic or unstable skin ulcer 2.Written informed consent by patient himself

Exclusion criteria

Exclusion criteria: 1.anemia 2.thrombocytopenia 3.local infection 4.malignancy

Design outcomes

Primary

Measure	Time frame
reduction ratio of wound area	—

Secondary

Measure	Time frame
period for complete wound closure, mean times of PRP application, mean platelet concentration, pathological examination of granulation tissue, epithelialization of wound margin, etc.	—

Countries

Japan

Contacts

Public ContactTakanobu MASHIKO

Saitama Medical Center Plasctic and Cosmetic Surgery

takanobu-mashiko@umin.ac.jp049-228-3400

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026